EnzymeBioSystems | Balance Sheet

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
25.60
416.40
270.50
140.00
41.20
Other Current Assets
-
40.00
-
-
3.00
Total Current Assets
25.60
456.40
270.50
140.00
44.20
Total Assets
25.60
456.40
270.50
140.00
44.20
ST Debt & Current Portion LT Debt
60.00
-
-
-
-
Other Current Liabilities
16.50
16.70
9.20
4.10
4.10
Total Current Liabilities
76.50
16.70
9.20
4.10
4.10
Total Liabilities
76.50
16.70
9.20
4.10
4.10
Common Equity (Total)
51.90
434.70
258.80
133.40
37.60
Total Shareholders' Equity
50.90
439.70
261.30
135.90
40.10
Total Equity
50.90
439.70
261.30
135.90
40.10
Liabilities & Shareholders' Equity
25.60
456.40
270.50
140.00
44.20
Preferred Stock (Carrying Value)
1.00
5.00
2.50
2.50
2.50

About EnzymeBioSystems

View Profile
Address
8440 West Lake Mead
Las Vegas Nevada 89128
United States
Employees -
Website http://enzymebiosystems.org
Updated 07/08/2019
EnzymeBioSystems engages in manufacturing specialty enzymes and enzyme related products. The company utilizes enzyme technologies to develop commercial solutions for applications within the specialty chemical industry. It plans to work collaboratively with industrial companies to develop differentiated enzyme solutions for target markets.